Pay in 4 interest-free payments of $2.50 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
lowering single-supplier hold-up risk
VK2809 is a promising asset for Viking Therapeutics in the MASH market
the design services segment saw a 20% revenue increase in Q4 2024
These users offer steady
affecting decisions
GLOBANT PORTER'S FIVE FORCES TEMPLATE RESEARCH B_36 lowering single-supplier hold-up riskGo Beyond the Preview Access the Full Strategic Report Globant faces moderate buyer power, rising substitute threats from low cost digital shops, and intense rivalry among agile tech providers while its scale and innovation edge limit supplier and entrant risks; this brief snapshot only scratches the surface. Unlock the full Porter's Five Forces Analysis to explore Globant's competitive dynamics, market pressures, and strategic advantages in detail.
US$ 425.00
US$ 237.50
US$ 303.50
US$ 110.00
US$ 7900.00
US$ 180.00
US$ 185.00
US$ 4475.00
US$ 145.00
US$ 51.24
US$ 2108.50
US$ 463.50
US$ 83400.00
